Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 80 (1) , 103-108
Abstract
Objectives To assess axial involvement on MRI in early peripheral spondyloarthritis (pSpA) and to evaluate whether axial inflammation predicts relapse on treatment withdrawal. Methods Fifty-six patients with early, active, newly diagnosed pSpA underwent MRI of the sacroiliac joints (SIJs) and spine prior to golimumab initiation. At sustained clinical remission of pSpA, treatment was withdrawn and a second MRI was performed. Bone marrow oedema (BME) was scored by three readers according to the Spondyloarthritis Research Consortium of Canada (SPARCC) method. Scores were compared with an axial spondyloarthritis cohort (Belgian Arthritis and Spondylitis cohort). Structural lesions were assessed using a similar method. Furthermore, fulfilment of the Assessment of Spondyloarthritis International Society (ASAS) definition of a positive MRI for sacroiliitis was assessed. Spinal images were evaluated for BME and structural lesions using the Canada-Denmark MRI spine scoring system by two readers. Results Thirty-six per cent showed SIJ BME at baseline, all fulfilling the ASAS definition of sacroiliitis. No association with back pain was found. Twenty-one per cent displayed SIJ structural lesions. Spinal BME was limited: the median inflammation scores were low and no patients had ≥5 inflammatory corner lesions. On clinical remission, a significant decrease in SIJ SPARCC scores was detected. On clinical remission, no significant differences in SIJ SPARCC scores were noted between patients relapsing and those maintaining remission after treatment discontinuation. Conclusion In patients with early pSpA, a surprisingly high prevalence of sacroiliitis on MRI was observed; SPARCC scores decreased significantly on tumour necrosis factor inhibition. Residual inflammation on MRI was not predictive of relapse of peripheral manifestations. No relevant inflammatory spinal involvement was detected. Collectively, our findings suggest a higher inflammatory burden in patients with early pSpA than anticipated.Keywords
Funding Information
- Janssen Pharmaceutica
This publication has 46 references indexed in Scilit:
- The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in generalAnnals of the Rheumatic Diseases, 2011
- The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progressAnnals of the Rheumatic Diseases, 2011
- Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic ArthritisThe Journal of Rheumatology, 2010
- Axial Psoriatic Arthritis: Update on a Longterm Prospective StudyThe Journal of Rheumatology, 2009
- Clinically Asymptomatic Axial Disease in Psoriatic Spondyloarthropathy. A Retrospective StudyClinical Rheumatology, 2002
- PSORIATIC ARTHRITISRheumatic Disease Clinics of North America, 1998
- Natural history of psoriatic arthritisBailliere's Clinical Rheumatology, 1994
- Psoriatic spondyloarthropathy: a long term prospective study.Annals of the Rheumatic Diseases, 1988
- Seronegative polyarthritis. a unified conceptArthritis & Rheumatism, 1978
- ASSOCIATIONS BETWEEN ANKYLOSING SPONDYLITIS, PSORIATIC ARTHRITIS, REITERʼS DISEASE, THE INTESTINAL ARTHROPATHIES, AND BEHCETʼS SYNDROMEMedicine, 1974